Hsquin
Indicated to address autoimmune and parasitic conditions to manage physical joint pain and support systemic tissue healing.
- Categories
- Antiparasitics · Diabetes Management
- Active ingredient
- Hydroxychloroquine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 200mg · 300mg · 400mg
Prescription and consultation requirements for Hsquin vary by destination and are determined by the fulfilment partner.
Hsquin details
- Alternative names
- hydroxychloroquine
- Therapeutic class
- Disease-Modifying Antirheumatic Drug (DMARD)
- Pharmacological class
- Aminoquinoline
- Known off-label uses
- sjogren's syndrome
- Contraindications
- history of retinal or macular disease; hypersensitivity to aminoquinolines
- Minor side effects
- nausea; abdominal pain; headache
- Moderate side effects
- dizziness; mild rash; unstable mood
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Healing Pharma
- Onset Time
- 2–4 weeks
- Duration
- 1–2 weeks
- Storage instructions
- Store below 25°C.
- Drug interactions
- Digoxin; Cimetidine; Amiodarone
- Age restrictions
- Approved for paediatric and adult populations.
Serious side effects
irreversible retinopathy, requires immediate medical attention; severe cardiomyopathy, requires immediate medical attention
Patient summary
indicated to address autoimmune and parasitic conditions to manage physical joint pain and support systemic tissue healing.
Mechanism of action
Inhibits intracellular lysosomal activity, reducing autoantigen presentation and suppressing cytokine release in immune cells.
Pregnancy and breastfeeding
TGA Category C: Benefits of disease control usually outweigh risks. Breastfeeding: Compatible.